Suppr超能文献

不同蛋白激酶 C 同工酶通过不同的 G 蛋白偶联受体介导对心脏快速激活延迟整流钾电流的抑制。

Different protein kinase C isoenzymes mediate inhibition of cardiac rapidly activating delayed rectifier K current by different G-protein coupled receptors.

机构信息

Department of Pharmacology, Hebei Medical University, Shijiazhuang, China; The Key Laboratory of New Drug Pharmacology and Toxicology, Shijiazhuang, China; The Key Laboratory of Neural and Vascular Biology, Ministry of Education, Shijiazhuang, China.

Hebei Institute for Drug Control, Shijiazhuang, China.

出版信息

Br J Pharmacol. 2017 Dec;174(23):4464-4477. doi: 10.1111/bph.14049. Epub 2017 Nov 7.

Abstract

BACKGROUND AND PURPOSE

Elevated angiotensin II (Ang II) and sympathetic activity contributes to a high risk of ventricular arrhythmias in heart disease. The rapidly activating delayed rectifier K current (I ) carried by the hERG channels plays a critical role in cardiac repolarization, and decreased I is involved in increased cardiac arrhythmogenicity. Stimulation of α -adrenoreceptors or angiotensin II AT receptors is known to inhibit I via PKC. Here, we have identified the PKC isoenzymes mediating the inhibition of I by activation of these two different GPCRs.

EXPERIMENTAL APPROACH

The whole-cell patch-clamp technique was used to record I in guinea pig cardiomyocytes and HEK293 cells co-transfected with hERG and α -adrenoreceptor or AT receptor genes.

KEY RESULTS

A broad spectrum PKC inhibitor Gö6983 (not inhibiting PKCε), a selective cPKC inhibitor Gö6976 and a PKCα-specific inhibitor peptide, blocked the inhibition of I by the α -adrenoreceptor agonist A61603. However, these inhibitors did not affect the reduction of I by activation of AT receptors, whereas the PKCε-selective inhibitor peptide did block the effect. The effects of angiotensin II and the PKCε activator peptide were inhibited in mutant hERG channels in which 17 of the 18 PKC phosphorylation sites were deleted, whereas a deletion of the N-terminus of the hERG channels selectively prevented the inhibition elicited by A61603 and the cPKC activator peptide.

CONCLUSIONS AND IMPLICATIONS

Our results indicated that inhibition of I by activation of α -adrenoreceptors or AT receptors were mediated by PKCα and PKCε isoforms respectively, through different molecular mechanisms.

摘要

背景与目的

血管紧张素 II(Ang II)和交感神经活性升高会增加心脏病患者发生室性心律失常的风险。由 hERG 通道携带的快速激活延迟整流钾电流(I )在心脏复极中起关键作用,而 I 的减少与心脏致心律失常性增加有关。已知刺激α-肾上腺素能受体或血管紧张素 II AT 受体可通过 PKC 抑制 I 。在这里,我们已经确定了介导这两种不同 GPCR 激活抑制 I 的 PKC 同工酶。

实验方法

使用全细胞膜片钳技术记录豚鼠心肌细胞和共转染 hERG 和α-肾上腺素能受体或 AT 受体基因的 HEK293 细胞中的 I 。

主要结果

广谱 PKC 抑制剂 Gö6983(不抑制 PKCε)、选择性 cPKC 抑制剂 Gö6976 和 PKCα 特异性抑制剂肽阻断了α-肾上腺素能受体激动剂 A61603 对 I 的抑制。然而,这些抑制剂对 AT 受体激活引起的 I 减少没有影响,而 PKCε 选择性抑制剂肽则阻断了这种作用。在 18 个 PKC 磷酸化位点中有 17 个缺失的突变 hERG 通道中,血管紧张素 II 和 PKCε 激活肽的作用被抑制,而 hERG 通道的 N 端缺失则选择性地阻止了 A61603 和 cPKC 激活肽引起的抑制作用。

结论和意义

我们的结果表明,α-肾上腺素能受体或 AT 受体的激活抑制 I 分别由 PKCα 和 PKCε 同工酶介导,通过不同的分子机制。

相似文献

引用本文的文献

6
PKC regulation of ion channels: The involvement of PIP.PKC 对离子通道的调节:PIP 的参与。
J Biol Chem. 2022 Jun;298(6):102035. doi: 10.1016/j.jbc.2022.102035. Epub 2022 May 16.
8
Diacylglycerol kinases regulate TRPV1 channel activity.二酰基甘油激酶调节 TRPV1 通道活性。
J Biol Chem. 2020 Jun 12;295(24):8174-8185. doi: 10.1074/jbc.RA119.012505. Epub 2020 Apr 28.

本文引用的文献

2
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes.《2015/16药理学简明指南:酶》
Br J Pharmacol. 2015 Dec;172(24):6024-109. doi: 10.1111/bph.13354.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验